DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 07 · Volume 33 · October 2007 DOI: 10.1055/s-002-7329 Inhibitors of Hemostatic System in Cancer: Basic and Clinical Aspects Guest Editors, Marek Z. Wojtukiewicz, M.D., and Ewa Sierko, M.D.

Erratum

e1
Amirkhosravi, Ali; Meyer, Todd; Amaya, Mildred; Davila, Monica; Mousa, Shaker A.; Robson, Theresa; Francis, John L.: Erratum: The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

PREFACE

621
Wojtukiewicz, Marek Z.; Sierko, Ewa; Kisiel, Walter: The Role of Hemostatic System Inhibitors in Malignancy
653
Sierko, Ewa; Wojtukiewicz, Marek Z.; Kisiel, Walter: The Role of Tissue Factor Pathway Inhibitor-2 in Cancer Biology
660
667
673
Hanly, Ann M.; Winter, Desmond C.: The Role of Thrombomodulin in Malignancy
695
707

Review Article

643
Amirkhosravi, Ali; Meyer, Todd; Amaya, Mildred; Davila, Monica; Mousa, Shaker A.; Robson, Theresa; Francis, John L.: The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis